Side-by-side comparison of AI visibility scores, market position, and capabilities
Houston polyolefins/chemicals (NYSE: LYB) ~$40B revenue; 10M metric ton polyolefins, MoReTec molecular recycling, refinery closure for core focus, CDP climate A score competing with Dow Chemical and SABIC.
LyondellBasell Industries N.V. is a Houston, Texas-based global polyolefins and chemicals company — publicly traded on the New York Stock Exchange (NYSE: LYB) as an S&P 500 Materials component — manufacturing polypropylene, polyethylene, propylene oxide, styrenic polymers, and specialty chemical compounds used in plastics for packaging, automotive parts, pipes, and consumer products through approximately 29,000 employees in 100 manufacturing sites across 22 countries. LyondellBasell is one of the world's largest plastics, chemicals, and refining companies, producing approximately 10 million metric tons of polyolefins annually — polyethylene and polypropylene that are the input materials for the plastic packaging, consumer goods containers, automotive components, and construction materials that the global economy requires. In 2024, LyondellBasell published its sustainability report with an improved CDP climate change score of A (up from A-) and progress toward sourcing 50% of electricity from renewable sources by 2030. CEO Peter Vanacker has led the company's strategic repositioning toward higher-margin specialty chemicals, circular economy plastics recycling, and portfolio optimization — including the announced closure of the Houston refinery (one of the largest US refinery closures in recent years) to focus on core polyolefins and chemicals, and the development of molecular recycling technology for post-consumer plastic waste through the MoReTec advanced recycling program.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.